Article ; Online: The valley of death: why Australia failed to develop clinically effective drugs in COVID-19.
2023 Volume 53, Issue 12, Page(s) 2175–2179
Abstract: There is a paucity of public discussion of costs spent on drug trials during coronavirus disease 2019 (COVID-19) and their value, and of large public outlay on research funding for vaccine and drug development that did not deliver medicines nor vaccines ... ...
Abstract | There is a paucity of public discussion of costs spent on drug trials during coronavirus disease 2019 (COVID-19) and their value, and of large public outlay on research funding for vaccine and drug development that did not deliver medicines nor vaccines for Australians. This oversight left us at the behest of global supply chains, politics and commercial cost-plus pricing for vaccines. It is possible that these outcomes were the result of some major cognitive biases and the failure of a clinical pharmacologist's voice in the leadership teams. Biases included unawareness of the complexities of taking interesting chemicals in vitro to development into therapeutic use that can be tolerated, show efficacy and have appropriate disposition in humans; lack of a systems approach to therapeutic development; and an understanding of the relevance and translatability of pharmacology, physiology and clinical drug development. We believe that reflecting on and addressing these biases will help Australia reposition itself better with a therapeutics and clinical trial strategy for future pandemics, built into the strategy of a Centre for Disease Control. |
---|---|
MeSH term(s) | Humans ; Australia/epidemiology ; COVID-19 ; Vaccines ; COVID-19 Drug Treatment ; Antiviral Agents ; Drug Development |
Chemical Substances | Vaccines ; Antiviral Agents |
Language | English |
Publishing date | 2023-12-05 |
Publishing country | Australia |
Document type | Journal Article |
ZDB-ID | 2045436-3 |
ISSN | 1445-5994 ; 1444-0903 |
ISSN (online) | 1445-5994 |
ISSN | 1444-0903 |
DOI | 10.1111/imj.16260 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 792: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 424: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.